Zinbryta treats multiple sclerosis. It is injected under the skin once a month.
Zinbryta is a prescription medication used to treat relapsing forms of multiple sclerosis.
It belongs to a group of drugs called interleukin blockers. These work by blocking the action of a protein involved with the body’s inflammatory response.
It is available as a long-acting injection and is typically administered under the skin (subcutaneously) each month.
Common side effects of Zinbryta include cold symptoms, upper respiratory tract infection, and rash.
Patient Ratings for
How was your experience with ?
Zinbryta Cautionary Labels
Zinbryta Drug Class
Zinbryta is part of the drug class: